Mankind Pharma: Market not much enthused by Mankind’s BSV buy

Mankind Pharma: Market not much enthused by Mankind’s BSV buy

Mumbai: It took a global private equity player to unite two home-bred Indian pharma companies for a deal. India’s fourth largest pharma company, Mankind Pharma, is set to acquire 100% stake in Bharat Serums & Vaccines (BSV) from global PE firm Advent International at ₹13,600 crore. After initially cheering the deal, the stock market gave … Read more

AstraZeneca to buy China’s Gracell Bio for up to $1.2 billion

AstraZeneca to buy China’s Gracell Bio for up to .2 billion

London: AstraZeneca said on Tuesday it will buy Gracell Biotechnologies for up to $1.2 billion as the Anglo-Swedish pharma company furthers its cell therapy ambitions and boosts its presence in China, the world’s second-largest pharmaceuticals market. The cash deal, which adds several experimental therapies to AstraZeneca’s portfolio, values Gracell at $2 per ordinary share, or … Read more